INNOVACAP1,165.00

Innova Captab Limited

· Pharma & Health
₹ CrorePeersMOREPENLABIOLCPFDCSENORESSANOFIORCHPHARMAGUJTHEMRPGLIFEMcap ₹6,667 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
INNOVACAP
FY26
MOREPENLAB
FY26
IOLCP
FY26
FDC
FY26
Peer
Median
Valuation — at last close
P/E47.30×66.76×45.20×20.03×45.20× +5%
P/B6.11×5.07×3.46×2.27×3.46× +77%
EV/EBITDA28.68×51.49×23.37×14.79×23.37× +23%
Market Cap₹6,667 Cr₹6,328 Cr₹6,223 Cr₹5,640 Cr₹6,223 Cr +7%
Growth
Revenue CAGR 3Y8.40%1.51%6.77%6.77%
Revenue CAGR 5Y8.73%10.24%9.48%
Net Income CAGR 3Y34.87%-0.36%13.23%13.23%
Revenue YoY (latest Q)33.94%34.07%37.08%2.97%34.07% -0%
Net Income YoY (latest Q)42.27%424.73%89.80%9.18%89.80% -53%
Profitability
EBITDA Margin14.90%6.96%11.60%15.94%11.60% +28%
Net Income Margin8.65%5.25%5.94%12.96%5.94% +46%
Return on Common Equity12.92%7.61%7.65%11.32%7.65% +69%
Return on Capital Employed14.73%6.17%9.95%11.23%9.95% +48%
Return on Assets7.67%4.90%5.32%9.64%5.32% +44%
Credit & Quality
Total Debt/Equity0.32×0.16×0.07×0.00×0.07× +357%
Interest Coverage11.70×5.43×12.97×57.54×12.97× -10%
Scale — latest FY
Revenue / Total Income₹1,630 Cr₹1,806 Cr₹2,319 Cr₹2,171 Cr₹2,171 Cr -25%
Net Income₹141 Cr₹94.9 Cr₹138 Cr₹281 Cr₹138 Cr +2%
Total Assets₹1,837 Cr₹1,936 Cr₹2,587 Cr₹2,919 Cr₹2,587 Cr -29%
EPS₹24.63₹1.73₹4.69₹17.29₹4.69 +425%
Book Value per Share₹190.61₹22.76₹61.27₹152.64₹61.27 +211%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.